Medtronic reports third quarter fiscal 2024 financial results

/CNW/ -- Medtronic plc (NYSE:MDT) today announced financial results for its third quarter (Q3) of fiscal year 2024 (FY24), which ended January 26, 2024. Key...

Related Keywords

Dublin ,Ireland ,Canada ,Israel ,Australia ,Japan ,Puerto Rico ,New Zealand ,United States ,Switzerland ,America ,Swiss ,Israeli ,Geoff Martha ,Ryan Weispfenning ,Nitron Cryoconsole ,Erika Winkels ,Karen Parkhill ,Peripheral Vascular Health ,Our Mission ,Pelvic Health ,Us Tax Court ,Exchange Commission ,Ablation Solutions ,Linkedin ,Central Lod District Court ,Inc Exp ,Medtronic Inc ,Medtronic ,European Union ,Renal Care Solutions ,Core Spine ,Cardiac Surgery ,Structural Heart ,Cardiac Pacing ,Patient Monitoring ,Respiratory Interventions ,Simplera Sync ,Cardiovascular Portfolio ,Cardiac Rhythm ,Heart Failure ,Peripheral Vascular ,Cardiac Rhythm Management ,Cardiac Pacing Therapies ,Cardiac Ablation Solutions ,Western Europe ,Vascular Embolization ,Neuroscience Portfolio ,Spinal Technologies ,Specialty Therapies ,Brain Modulation ,Pain Stim ,Medical Surgical Portfolio ,Medical Surgical ,General Surgical Technologies ,Advanced Surgical Technologies ,Acute Care ,Investor Events ,Transition Manufacturing Agreements ,Emerging Markets ,Middle East ,Latin America ,Eastern Europe ,Swiss Cantonal ,Private Securities Litigation Reform Act ,Annual Report ,